
Healthcare · NSE / BSE
Gujarat Kidney and Super Speciality Limited, incorporated in 2019, provides multispeciality healthcare services across Gujarat through a network of seven hospitals and four pharmacies, offering secondary and tertiary care. The company operates a total bed capacity of 490 beds, with 455 approved and 340 operational, across facilities in Vadodara, Godhra, Bharuch, Borsad, and Anand. Its services cover general and surgical treatments as well as super speciality procedures, including internal medicine, general and minimally invasive surgery, orthopaedics and trauma care, joint replacement, obstetrics and gynaecology, respiratory care, cardiology, diabetology, and anaesthesiology. As of June 30, 2025, the company’s operations are supported by 89 doctors, 332 nurses, and 338 other staff members.
Price Band
₹108 – ₹114
Issue Size
₹251 Cr
Lot Size
128 shares
GMP
+1.3%
Est. Listing
₹115.5
at current GMP
Subscribed
5.21x
overall
Open
22 Dec 2025
Close
24 Dec 2025
Allotment
26 Dec 2025
Refund
27 Dec 2025
Demat Credit
28 Dec 2025
Listing
30 Dec 2025
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹114
Band: ₹108 – ₹114
Estimated Listing Price
₹115.5
Upper price + GMP
Lot Size
128 shares
Min investment ₹14,592
Estimated Profit / Lot
₹192
128 × ₹1.5
Grey Market Premium trend
+₹1.5
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹1.5 | 1.3% | ₹115.5 |
| 30 Oct 2026 | +₹1.5 | 1.3% | ₹115.5 |
| 29 Oct 2026 | +₹1 | 1.2% | ₹115 |
GMP is unofficial market data. Not a guarantee of listing performance.
Gujarat Kidney And Super Speciality Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹250.8 Crores. The shares are offered at a price band of ₹108 to ₹114 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2025-12-24, the basis of allotment is scheduled to be finalized on 2025-12-26. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.
The latest grey market premium for Gujarat Kidney And Super Speciality Limited IPO is ₹1.5, which indicates an expected listing price of ₹115.5.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.